Figure 5
Figure 5. Synthetic interaction of megakaryocyte GATA-1 deficiency with P-TEFb inhibition. (A) GATA-1Lo mice (G1Lo) and age-matched wild-type C57BL/6 received 5 mg/kg per day of flavopiridol (FP; 5 mice per group) or saline control (4 mice per group) for 7 consecutive days. Blood samples from the retro-orbital plexus were then analyzed on a Hemavet automated analyzer for platelet counts. (B) Mice, as in panel A, received a 9-day course of flavopiridol (FP) at the same dose or saline. Marrows were then analyzed by FACS. In rows 1 and 2, marrow cells were costained with anti-CD41 and propidium iodide (PI). The CD41+ cells (percentages indicated in row 2) were gated for ploidy analysis using FlowJo software. Numbers in row 1 indicate percentage of total cells within each ploidy category. In rows 3 and 4, marrow cells were costained antibodies to CD41, TER119 (erythroid marker), and CD71 (transferrin receptor), with quadrant percentages as indicated.

Synthetic interaction of megakaryocyte GATA-1 deficiency with P-TEFb inhibition. (A) GATA-1Lo mice (G1Lo) and age-matched wild-type C57BL/6 received 5 mg/kg per day of flavopiridol (FP; 5 mice per group) or saline control (4 mice per group) for 7 consecutive days. Blood samples from the retro-orbital plexus were then analyzed on a Hemavet automated analyzer for platelet counts. (B) Mice, as in panel A, received a 9-day course of flavopiridol (FP) at the same dose or saline. Marrows were then analyzed by FACS. In rows 1 and 2, marrow cells were costained with anti-CD41 and propidium iodide (PI). The CD41+ cells (percentages indicated in row 2) were gated for ploidy analysis using FlowJo software. Numbers in row 1 indicate percentage of total cells within each ploidy category. In rows 3 and 4, marrow cells were costained antibodies to CD41, TER119 (erythroid marker), and CD71 (transferrin receptor), with quadrant percentages as indicated.

Close Modal

or Create an Account

Close Modal
Close Modal